China Digest: Zion Pharma raises $20m round; Langsin Venture closes $17m fund

Source: Laurynas Mereckas/Unsplash

Chinese pharmaceutical firm Zion Pharma has secured nearly $20 million in a Series A+ round of financing, while early-stage investment company Langsin Venture has closed a new RMB-denominated fund at 120 million yuan ($17 million).

Zion Pharma raises nearly $20m Series A+ round

Zion Pharma, a Chinese startup that develops small molecule anti-tumour drugs, has secured nearly $20 million in a Series A+ round of financing jointly led by Qiming Venture Partners and Beijing-based investment firm Sherpa Healthcare Partners.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter